COVID - 19 Vaccination Update - Day 535 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 41 Second

Posted On: 04 JUL 2022 8:08 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 198 Crore (1,98,08,49,980) landmark milestone today. More than 10 lakh (10,09,757) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10409191
	2^nd Dose	10067993
	Precaution Dose	5758397
FLWs	1^st Dose	18424608
	2^nd Dose	17630495
	Precaution Dose	10494571
Age Group 12-14 years	1^st Dose	36988142
	2^nd Dose	24135973
Age Group 15-18 years	1^st Dose	60545157
	2^nd Dose	49113939
Age Group 18-44 years	1^st Dose	558386200
	2^nd Dose	502487923
	Precaution Dose	3319256
Age Group 45-59 years	1^st Dose	203469958
	2^nd Dose	193704654
	Precaution Dose	2738734
Over 60 years	1^st Dose	127282661
	2^nd Dose	121005286
	Precaution Dose	24886842
Cumulative 1^st dose administered		1015505917
Cumulative 2^nd dose administered		918146263
Precaution Dose		47197800
Total		1980849980

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 4^th July, 2022 (535^th Day)
HCWs	1^st Dose	63
	2^nd Dose	437
	Precaution Dose	13123
FLWs	1^st Dose	140
	2^nd Dose	888
	Precaution Dose	57554
Age Group 12-14 years	1^st Dose	74330
	2^nd Dose	149823
Age Group 15-18 years	1^st Dose	25366
	2^nd Dose	73389
Age Group 18-44 years	1^st Dose	28148
	2^nd Dose	221022
	Precaution Dose	77479
Age Group 45-59 years	1^st Dose	4504
	2^nd Dose	47715
	Precaution Dose	36823
Over 60 years	1^st Dose	4466
	2^nd Dose	32745
	Precaution Dose	161742
Cumulative 1^st dose administered		137017
Cumulative 2^nd dose administered		526019
Precaution Dose		346721
Total		1009757

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.